Sign in Start Free

CompanyHealthtech & BiotechEast Asia

SK Bioscience

Quiet

Korean vaccine developer and manufacturer with global partnerships

Add to Watchlist

Company Overview

Sectors

BiotechVaccines

Peer Comparison

10

5

3

Samsung Biologics

3

1

1

1

1

0

0

0

Signal Timeline

1 total

Date unknown

PartnershipCanonical—

SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine Development Financed by the European Union

SK Bioscience, with partners IDT Biologika and Vaxxas, was selected for an EU-financed project to develop a next-generation influenza vaccine.

Get SK Bioscience signal updates

Get notified when new signals are published for this company.

Explore More Industries

AI & Frontier Intelligence307 signals Fintech & Digital Finance168 signals Mobility, EV & Autonomous Systems163 signals Energy, Climate & Industrial Transition165 signals